Comparison of Global versus Epidermal Growth Factor Receptor Pathway Profiling for Prediction of Lapatinib Sensitivity in Bladder Cancer

Chemotherapy for metastatic bladder cancer is rarely curative. The recently developed small molecule, lapatinib, a dual epidermal growth factor receptor (EGFR)/human epidermal growth factor receptor-2 receptor tyrosine kinase inhibitor, might improve this situation. Recent findings suggest that iden...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Havaleshko, Dmytro M, Smith, Steven Christopher, Cho, HyungJun, Cheon, Sooyoung, Owens, Charles R, Lee, Jae K, Liotta, Lance A, Espina, Virginia, Wulfkuhle, Julia D, Petricoin, Emanuel F, Theodorescu, Dan
Format: Artigo
Langue:Inglês
Publié: Neoplasia Press Inc. 2009
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2767220/
https://ncbi.nlm.nih.gov/pubmed/19881954
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires